Search
Sitemap
Disclaimer
About Us
|
Product Progress
|
Patient Information
|
Investor's Corner
|
Career Opportunities
About Us
Strategic Growth
•
Message from Management
•
Fact Sheet
Diversified Assets
•
Product Pipeline
•
Intellectual Property
•
Manufacturing
•
Ceregene
•
Technology Available for Licensing
Management
•
Executive Committee
•
Board of Directors
•
Medical Advisory Board
Community Involvement
•
Our Contributions
•
Apply for Sponsorship
Calendar
Contact Us
Product Progress
Product Platforms
•
GVAX® Cancer Immunotherapies
•
Oncolytic Virus Therapies
Clinical Stage Portfolio
•
GVAX® Immunotherapy for Prostate Cancer
•
GVAX® Immunotherapy for Pancreatic Cancer
•
GVAX® Immunotherapy for Leukemia
•
CG0070 Bladder / Multiple
Preclinical Pipeline
•
CG5757 (Multiple)
Manufacturing
Research Library
•
Bibliography
•
Glossary
•
Industry Links
Back to Top
Patient Information
Clinical Trials
•
GVAX® Immunotherapy for Prostate Cancer
•
GVAX® Immunotherapy for Pancreatic Cancer
•
GVAX® Immunotherapy for Leukemia
•
CG0070 Bladder
Patient's Library
•
What are Clinical Trials?
•
What are Cancer Immunotherapies?
•
What Are Oncolytic Immunotherapies?
•
Bibliography
•
Glossary
•
Industry Links
•
Patient Links
Back to Top
Investor's Corner
Stockholder Information
•
Stock Quote
Corporate Governance
News
•
Press Release Archives
Calendar
Investor's Library
•
Annual Reports
•
EDGAR Filings (Section 16)
Information Request
•
Press Release Alert
Career Opportunities
Why Cell Genesys?
•
Diversity Statement
Benefits
•
... And More!
Current Opportunities
•
How to Apply
•
Recruitment Calendar
•
Message to Recruiters
Back to Top
About Us
|
Product Progress
|
Patient Information
|
Investor's Corner
|
Career Opportunities
©2008 Cell Genesys, Inc. | Site Design:
Heiney & Craig, Inc.
|
Home
|
Search
|
Contact Us
